Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes

被引:259
|
作者
Wen, Li [1 ]
Duffy, Andrew [2 ]
机构
[1] Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA
关键词
microbiota; diet; yogurt; type; 2; diabetes; inflammation; environment; CLOSTRIDIUM-DIFFICILE INFECTION; CHAIN FATTY-ACIDS; DIET-INDUCED OBESITY; INTESTINAL MICROBIOTA; YOGURT CONSUMPTION; CESAREAN-SECTION; INSULIN-RESISTANCE; CHILDHOOD OBESITY; IMMUNE-RESPONSE; MILK MICROBIOTA;
D O I
10.3945/jn.116.240754
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The gut microbiota is a complex community of bacteria residing in the intestine. Animal models have demonstrated that several factors contribute to and can significantly alter the composition of the gutmicrobiota, including genetics; the mode of delivery at birth; the method of infant feeding; the use of medications, especially antibiotics; and the diet. There may exist a gut microbiota signature that promotes intestinal inflammation and subsequent systemic low-grade inflammation, which in turn promotes the development of type 2 diabetes. There are preliminary studies that suggest that the consumption of probiotic bacteria such as those found in yogurt and other fermented milk products can beneficially alter the composition of the gut microbiome, which in turn changes the host metabolism. Obesity, insulin resistance, fatty liver disease, and low-grade peripheral inflammation are more prevalent in patients with low a diversity in the gut microbiome than they are in patients with high a diversity. Fermented milk products, such as yogurt, deliver a large number of lactic acid bacteria to the gastrointestinal tract. They may modify the intestinal environment, including inhibiting lipopolysaccharide production and increasing the tight junctions of gut epithelia cells.
引用
收藏
页码:1468S / 1475S
页数:8
相关论文
共 50 条
  • [41] Exploring the gut microbiota in patients with pre-diabetes and treatment naive diabetes type 2-a pilot study
    Gravdal, Kristin
    Kirste, Katrine H.
    Grzelak, Krzysztofa
    Kirubakaran, Graceline Tina
    Leissner, Philippe
    Saliou, Adrien
    Casen, Christina
    BMC ENDOCRINE DISORDERS, 2023, 23 (01)
  • [42] Gut microbiota and diabetes: from pathogenesis to therapeutic perspective
    Burcelin, Remy
    Serino, Matteo
    Chabo, Chantal
    Blasco-Baque, Vincent
    Amar, Jacques
    ACTA DIABETOLOGICA, 2011, 48 (04) : 257 - 273
  • [43] The association of type II diabetes with gut microbiota composition
    Navab-Moghadam, Fatemeh
    Sedighi, Mansour
    Khamseh, Mohammad E.
    Alaei-Shahmiri, Fariba
    Talebi, Malihe
    Razavi, Shabnam
    Amirmozafari, Nour
    MICROBIAL PATHOGENESIS, 2017, 110 : 630 - 636
  • [44] Gut microbiota influence in type 2 diabetes mellitus (T2DM)
    Cunningham, A. L.
    Stephens, J. W.
    Harris, D. A.
    GUT PATHOGENS, 2021, 13 (01)
  • [45] Dietary SCFAs Immunotherapy: Reshaping the Gut Microbiota in Diabetes
    Yap, Yu Anne
    Marino, Eliana
    DIABETES: FROM RESEARCH TO CLINICAL PRACTICE, VOL 4, 2021, 1307 : 499 - 519
  • [46] Gut microbiota dysbiosis-associated obesity and its involvement in cardiovascular diseases and type 2 diabetes. A systematic review
    Hamjane, Nadia
    Mechita, Mohcine Bennani
    Nourouti, Naima Ghailani
    Barakat, Amina
    MICROVASCULAR RESEARCH, 2024, 151
  • [47] Microbes On-Air Gut and Tissue Microbiota as Targets in Type 2 Diabetes
    Serino, Matteo
    Blasco-Baque, Vincent
    Burcelin, Remy
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2012, 46 (09) : S27 - S28
  • [48] The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus
    Kootte, R. S.
    Vrieze, A.
    Holleman, F.
    Dallinga-Thie, G. M.
    Zoetendal, E. G.
    de Vos, W. M.
    Groen, A. K.
    Hoekstra, J. B. L.
    Stroes, E. S.
    Nieuwdorp, M.
    DIABETES OBESITY & METABOLISM, 2012, 14 (02) : 112 - 120
  • [49] Role of gut microbiota in the pathogenesis of type 2 diabetes mellitus (literature review)
    Koval, S. M.
    Snihurska, I. O.
    MEDICNI PERSPEKTIVI, 2021, 26 (04): : 22 - 30
  • [50] The gut microbiota in type 1 diabetes: friend or foe?
    Gavin, Patrick G.
    Hamilton-Williams, Emma E.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2019, 26 (04) : 207 - 212